cyclosporine has been researched along with Asthma, Bronchial in 108 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 59 (54.63) | 18.2507 |
| 2000's | 33 (30.56) | 29.6817 |
| 2010's | 14 (12.96) | 24.3611 |
| 2020's | 2 (1.85) | 2.80 |
| Authors | Studies |
|---|---|
| Ballaron, S; BaMaung, NY; Basha, A; Bauch, J; Carter, GW; Chen, YW; Chiou, XG; Djuric, SW; Fey, T; Gauvin, D; Gubbins, E; Hsieh, GC; Liu, H; Luly, JR; Madar, DJ; Marsh, KC; Mollison, KW; Pong, M; Sciotti, RJ; Shaughnessy, TK; Sheets, MP; Smith, M; Trevillyan, JM; Tu, NP; Wagenaar, FL; Warrior, U; Wegner, CD; Wiedeman, PE; Zhou, X | 1 |
| Adam, DN; Beecker, JR; Gooderham, MJ; Hong, CH; Jack, CS; Jain, V; Lansang, P; Lynde, CW; Papp, KA; Prajapati, VH; Turchin, I; Yeung, J | 1 |
| Abe, K; Ait-Oufella, H; Alacamli, G; Alacamli, OG; Amir, O; Antar, S; Ashour, H; Azimonti, G; Baba, Y; Balogun, MM; Bampidis, V; Bastos, ML; Ben Hamouda, N; Bickel Haase, T; Bjornsson, R; Bostan, M; Braik, R; Brantom, P; Briggs, S; Bujor, I; Canbek, TD; Cherecheanu, AP; Chesson, A; Choudhary, RJ; Christensen, H; Chung, HR; Clavier, T; Dahman, NBH; Dani, S; Demailly, Z; Devine, LD; Ding, G; Duan, X; Durjava, M; Dusemund, B; Edebali, S; Elbaz Greener, G; Elnoby, AS; Fang, Q; Fares, AM; Fashola, MB; Fawzy, MS; Fouad, FM; Fu, SZ; Fujita, S; Furusawa, S; Gallagher, AM; Gao, J; Goyal, N; Guo, J; Hamuda, N; Han, Y; Hariri, G; Heist, EK; Hill, AJ; Homoud, M; Hu, Q; Hu, Z; Huang, L; Ide, T; Ikeda, M; Ishimaru, K; Jiang, C; Kaderli, ST; Kanamura, T; Karalezli, A; Kaur, P; Kazatsker, M; Kobo, O; Kouba, M; Kumar, R; Lavillegrand, JR; Leshem, E; Li, A; Li, S; Liu, R; López Puente, S; López-Alonso, M; Ma, M; Madias, C; Manini, P; Marcon, F; Margolis, G; Matsushima, S; Mayo, B; Miller, JE; Miyake, R; Miyamoto, HD; Naumann-Gola, S; Ortner, E; Pandit, R; Pang, Y; Pechová, A; Petkova, M; Pîrvulescu, R; Popa-Cherecheanu, A; Ramos, F; Roguin, A; Rozen, G; Ruskin, JN; Sanz, Y; Schweiggert-Weisz, U; Shafie, AAA; Sharma, H; Shi, X; Stoicescu, EA; Stopyra, W; Suh, JD; Sul, S; Tamion, F; Tiu, C; Tohyama, T; Tsutsui, H; Tsutsui, Y; Vandestienne, M; Villa, RE; Wang, P; Watanabe, M; Westendorf, J; Woutersen, R; Xia, J; Xing, W; Xu, X; Yang, L; Yang, N; Yu, J; Yu, M; Yu, X; Zhang, L; Zhao, Y; Zhao, Z; Zhou, X; Zorn, H | 1 |
| Ikutani, M; Iseki, M; Kudo, F; Takaki, S | 1 |
| Kawabata, Y; Kojo, Y; Mizumoto, T; Ogawa, K; Onoue, S; Sato, H; Yamada, S | 1 |
| Chen, Z; Li, W; Shen, H; Wu, Y; Yan, F; Ying, S; Zhou, H | 1 |
| Leach, SB; Nafe, LA | 1 |
| Duse, M; Nebbioso, M; Occasi, F; Petrarca, L; Salvatori, G; Zicari, AM | 1 |
| Choi, JJ; Hwang, ES; Jin, M; Kim, DH; Kim, JS; Park, BK; Park, S; Yun, CY | 1 |
| Hashimoto, N; Kawabata, Y; Mizumoto, T; Onoue, S; Sato, H; Yamada, S | 1 |
| Hillman, T; Murphy, P; Rajakulasingam, K | 1 |
| Bassett, D; Doyon-Reale, N; Gao, X; Hirata, F; Kannan, R; Kerr, J; Lieh-Lai, M; Wilson, S | 1 |
| Bush, A; Saglani, S | 1 |
| Balsley, MA; Bukrinsky, MI; Constant, SL; Damsker, JM; Jurjus, RA; Stemmy, EJ | 1 |
| Aoki, Y; Kawabata, Y; Kojo, Y; Mizumoto, T; Ogawa, K; Onoue, S; Sato, H; Wada, K; Yamada, S | 1 |
| Fratianni, C; Gonzales, M; Khardori, R; Mamillapali, C | 1 |
| Ishii, H; Kondo, T; Tazaki, G; Tsunoda, T; Uruma, T; Watanabe, H | 1 |
| Hong, JH; Kim, SH; Lee, YC | 1 |
| Onoue, S | 1 |
| Abal, AT; Abul, HT; Haines, DD; Mahmoud, FF; Wise, JA | 1 |
| Kay, AB; Larché, M; Robinson, DS | 1 |
| Eckstein, JW; Fung, J | 1 |
| Argyros, G; Niven, AS | 1 |
| Chung, KF; Eynott, PR; Huang, TJ; Nicklin, PL; Oates, T; Salmon, M | 1 |
| Corrigan, CJ | 1 |
| Kon, OM | 1 |
| Barnes, NC; Kay, AB; Khan, LN; Meng, Q; Ying, S | 1 |
| Fukaya, H; Fuyumuro, T; Hoshiko, K; Iimura, A; Nabeshima, T; Noji, S | 1 |
| Arikan, C; Aydogdu, S; Kilic, M; Tokat, Y | 1 |
| Chen, JQ; Chen, Y; Xie, QM; Yang, QH | 1 |
| Chen, YH; Pang, YZ; Tang, CS; Yao, WZ; Zhao, MW | 1 |
| Kim, SH; Lee, JC; Lee, YC; Roh, SS; Seo, YB | 1 |
| Auriola, S; Jarho, P; Järvinen, K; Järvinen, T; Matilainen, L; Näsi, E; Toropainen, T | 1 |
| Kim, SH; Lee, JC; Lee, YC; Roh, SS; Seo, YB; Yeum, HS | 1 |
| Kim, SH; Lee, YC; Roh, SS; Seo, YB | 1 |
| Etoh, T; Ito, K; Kaminuma, O; Matsuzaki, G; Mori, A; Nakagawa, H; Nishizaki, Y; Okudaira, H; Suko, M; Tsuruoka, N | 1 |
| Hossain, M; Okubo, Y; Sekiguchi, M | 3 |
| Ito, K; Kaminuma, O; Kobayashi, S; Matsuzaki, G; Mori, A; Nishizaki, Y; Okudaira, H; Suko, M; Tsuruoka, N; Yamamoto, K | 1 |
| Klein, RM; Leschke, M; Strauer, BE | 1 |
| Bochenek, G; Domagała, B; Nizankowska, E; Pajak, A; Pinis, G; Soja, J; Szczeklik, A; Sładek, K | 1 |
| Hill, JM; Tattersfield, AE | 1 |
| Asakawa, J; Fukuda, T; Makino, S; Motojima, S | 1 |
| Alexander, AG; Barnes, NC; Corrigan, CJ; Kay, AB | 2 |
| Moss, RB | 1 |
| Arima, M; Makino, S; Terashi, Y; Yukawa, T | 2 |
| Cook, RJ | 1 |
| Chapman, I; Mazzoni, L | 1 |
| Adachi, M; Horikoshi, S; Imai, T; Kimura, T; Kokubu, F; Mita, S; Tokunaga, H | 1 |
| Alexander, A; Assoufi, B; Brown, P; Corrigan, C; Haczku, A; Kay, AB; Li, B | 1 |
| Magnussen, H | 1 |
| Barnes, NC; Kay, AB; Lock, SH | 1 |
| Azuma, M; Matsunaga, Y; Nakamura, Y; Ogura, T; Ogushi, F; Okano, Y; Sano, T; Shimizu, E; Sone, S; Takahashi, T | 1 |
| Assem, ES; Bovingdon, M; Wan, BY | 1 |
| Busse, WW; Jarjour, NN; McGill, K | 1 |
| Kanwar, BA; Shehan, CJ | 1 |
| Corrigan, CJ; Kay, AB | 1 |
| Barnes, PJ | 1 |
| Assoufi, B; Bungre, JK; Cooper, AE; Corrigan, CJ; Kay, AB; Seddon, H | 1 |
| Baumann, G; Borel, JF; Chapman, I; Donatsch, P; Fahr, A; Mueller, EA; Vigouret, JM | 1 |
| Asakura, Y; Hosino, A; Kaminuma, O; Mikami, T; Mori, A; Nagahori, T; Nishizaki, Y; Ohmura, T; Okudaira, H; Suko, M | 1 |
| Spector, SL | 1 |
| Floreani, AA; Rennard, SI | 1 |
| Barnes, NC; Durham, SR; Kay, AB; Kon, OM; Sihra, BS; Walker, S | 1 |
| Kay, AB | 2 |
| Agis, H; Lechner, K; Liehl, E; Scheiner, O; Semper, H; Sperr, M; Sperr, WR; Susani, M; Valent, P; Valenta, R; Willheim, M | 1 |
| Alessandrini, C; Difonzo, EM; Faggi, E; Miracco, C; Paccagnini, E; Romano, C; Valenti, L | 1 |
| Hardinge, FM; Holgate, ST; Howarth, PH; Madden, J; Redington, AE | 1 |
| Bush, A; Coren, ME; Rosenthal, M | 1 |
| Barnes, NC; Kay, AB | 1 |
| Kon, OM; Robinson, DS | 1 |
| Nardini, S | 1 |
| Celikel, CA; Celikel, T; Ceyhan, BB; Sungur, M | 1 |
| Celikel, CA; Celikel, T; Ceyhan, B; Sungur, M | 1 |
| Cozzi, P; Leff, AR; Mitchell, RW; Ndukwu, IM; Padrid, PA; Spaethe, S | 1 |
| Aliperta, M; De Marino, V; Marone, G; Spadaro, G; Triggiani, M | 1 |
| Sullivan, R | 1 |
| Deykin, A; Israel, E | 1 |
| Balfour-Lynn, I | 1 |
| Legg, J; Warner, J | 1 |
| Akiyama, K; Egan, RW; Kaminuma, O; Mori, A; Nakata, A; Ogawa, K; Okudaira, H | 1 |
| Abul, H; Haines, D; Khadadah, M; Mahmoud, F; Morgan, G; Onadeko, B | 1 |
| Brguljan, PM; Cimerman, N; Kos, J; Krasovec, M; Suskovic, S | 2 |
| Cho, SH; Demissie-Sanders, S; Filler, SA; Oh, CK; Tam, SW | 1 |
| Barnes, NC; Kay, AB; Khan, LN; Kon, OM; Macfarlane, AJ; Meng, Q; Ying, S | 1 |
| Bouriot, JP; Calic, F; DeLeij, L; Harding, N; Jensen, BK; Kirkesseli, S; Ozoux, ML; Rohatagi, S | 1 |
| Dai, A; Zhang, P | 1 |
| Li, M | 1 |
| Cullinan, P; Evans, DJ; Geddes, DM | 1 |
| Cimerman, N; Kos, J; Krasovec, M; Mesko Brguljan, P; Suskovic, S | 1 |
| Bungre, J; Corrigan, C; Powell, N; Till, S | 1 |
| Bian, RL; Chen, JQ; Shen, WH; Xie, QM; Yang, QH | 1 |
| Brune, K; Kuss, H; Pahl, A; Szelenyi, I; Zhang, M | 1 |
| Brune, K; Friedrich, U; Horvath, K; Kuss, H; Magyar, Z; Pahl, A; Szekely, J; Szelenyi, I; Török, K; Zhang, M | 1 |
| Akutsu, I; Fukuda, T; Makino, S | 1 |
| Matusiewicz, R; Urbankowska, B | 1 |
| Alexander, AG; Barnes, NC; Kay, AB | 1 |
| Heitman, J | 1 |
| Nizankowska, E; Sladek, K; Szczeklik, A | 1 |
| Morley, J | 1 |
| Bukantz, SC; Calderón, E; Coffey, RG; Ledford, DK; Lockey, RF | 1 |
| Barnes, NC; Brown, PH; Corrigan, CJ; Frew, AJ; Kay, AB; Tsai, JJ | 1 |
31 review(s) available for cyclosporine and Asthma, Bronchial
| Article | Year |
|---|---|
Expert consensus on the systemic treatment of atopic dermatitis in special populations.
Topics: Aged; Asthma; Cyclosporine; Dermatitis, Atopic; Female; Humans; Methotrexate; Mycophenolic Acid | 2023 |
Topics: Adolescent; Adult; Animals; Asthma; Atrial Fibrillation; Autoantibodies; Biomarkers; Breast Neoplasms; Child; Conjunctivitis, Allergic; Cornea; COVID-19; Cyclosporine; Cytokines; Death, Sudden, Cardiac; Defibrillators, Implantable; Diet; Disease Models, Animal; Docetaxel; Double-Blind Method; Dry Eye Syndromes; Educational Status; Emulsions; Female; Fluorescein Angiography; Fluoresceins; Focus Groups; Heart Failure; Hemothorax; Humans; Inflammation; Keratoconus; Male; Meibomian Glands; Mice; Middle Aged; Multiple Sclerosis; Myocardial Infarction; Myocardium; Nerve Fibers; Nigeria; Obesity; Overweight; Pandemics; Primary Prevention; Prospective Studies; Qualitative Research; Registries; Retinal Ganglion Cells; Retinal Vessels; Schools; Sirolimus; Tertiary Care Centers; Th1 Cells; Th2 Cells; Tomography, Optical Coherence; Troponin I; Tumor Necrosis Factor-alpha; United States; Ventricular Remodeling | 2022 |
Therapeutic targets for persistent airway inflammation in refractory asthma.
Topics: Anti-Asthmatic Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Asthma; Cyclosporine; Drug Delivery Systems; Drug Resistance; Etanercept; Gold Compounds; Humans; Immunoglobulin G; Inflammation; Leukotriene Antagonists; Methotrexate; Omalizumab; Phosphodiesterase Inhibitors; Receptors, Tumor Necrosis Factor; Respiration Disorders | 2010 |
Management of severe asthma in children.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Allergens; Anti-Asthmatic Agents; Asthma; Azathioprine; Bronchial Provocation Tests; Bronchodilator Agents; Budesonide; Budesonide, Formoterol Fumarate Drug Combination; Child; Clinical Trials as Topic; Comorbidity; Cyclosporine; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Eosinophils; Ethanolamines; Formoterol Fumarate; House Calls; Humans; Immunoglobulin E; Interdisciplinary Communication; Methotrexate; Off-Label Use; Risk Factors; Severity of Illness Index; Spirometry; Terbutaline; Tobacco Smoke Pollution; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Immunotherapy in miscellaneous medical disorders Graves ophthalmopathy, asthma, and regional painful syndrome.
Topics: Allergens; Anti-Asthmatic Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antioxidants; Asthma; Azathioprine; Benzamides; Complex Regional Pain Syndromes; Cyclosporine; Decompression, Surgical; Etanercept; Glucocorticoids; Graves Ophthalmopathy; Humans; Imatinib Mesylate; Immunoglobulin G; Immunoglobulins, Intravenous; Immunosuppressive Agents; Immunotherapy; Octreotide; Omalizumab; Orbit; Piperazines; Pyridones; Pyrimidines; Radiotherapy Dosage; Receptors, Tumor Necrosis Factor; Risk Factors; Rituximab; Selenium | 2012 |
[Strategic formulation study on dry powder inhalation system based on modulated molecular properties and controlled pharmacokinetics].
Topics: Administration, Inhalation; Animals; Asthma; Chemistry, Pharmaceutical; Cyclosporine; Disease Models, Animal; Drug Discovery; Dry Powder Inhalers; Granulocytes; Humans; Immunosuppressive Agents; Metered Dose Inhalers; Pulmonary Disease, Chronic Obstructive | 2013 |
The role of T lymphocytes in the pathogenesis of asthma.
Topics: Adrenal Cortex Hormones; Animals; Antigen-Presenting Cells; Asthma; Cyclosporine; Cytokines; Humans; Immunosuppressive Agents; Phenotype; T-Lymphocytes; Th2 Cells | 2003 |
A new class of cyclosporin analogues for the treatment of asthma.
Topics: Animals; Asthma; Clinical Trials as Topic; Cyclosporine; Humans | 2003 |
Alternate treatments in asthma.
Topics: Anti-Asthmatic Agents; Anticoagulants; Asthma; Cyclosporine; Diuretics; Folic Acid Antagonists; Furosemide; Gold; Heparin; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; T-Lymphocytes; Troleandomycin | 2003 |
The role of the T cell in the immunopathogenesis of asthma.
Topics: Adult; Allergens; Anti-Asthmatic Agents; Asthma; CD4-Positive T-Lymphocytes; Chemokines; Child; Cyclosporine; Double-Blind Method; Drug Resistance; Glucocorticoids; Humans; Hypersensitivity, Immediate; Immunosuppressive Agents; Inflammation; Interleukins; Lymphocyte Activation; Randomized Controlled Trials as Topic; RNA, Messenger; T-Lymphocyte Subsets | 2000 |
Novel immunosuppressants in asthma.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Asthma; CD4 Antigens; Cross-Over Studies; Cyclosporine; Double-Blind Method; Humans; Immunosuppressive Agents; Methotrexate; Models, Immunological; Organogold Compounds; Randomized Controlled Trials as Topic; Sirolimus; Tacrolimus | 2000 |
Corticosteroid sparing agents in asthma.
Topics: Adrenal Cortex Hormones; Asthma; Cyclosporine; Gold; Humans; Hydroxychloroquine; Methotrexate | 1995 |
Alternative pharmacotherapies for steroid-dependent asthma.
Topics: Adrenal Cortex Hormones; Asthma; Clinical Trials as Topic; Cyclosporine; Dapsone; Furosemide; Gold; Humans; Hydroxychloroquine; Magnesium Sulfate; Methotrexate; Treatment Outcome; Troleandomycin | 1995 |
Mechanisms of inhibition by cyclosporin A on pulmonary leukocyte accumulation.
Topics: Animals; Asthma; Cyclosporine; Cytokines; Endothelium, Vascular; Epithelium; Humans; Leukocytes; Lung; Mast Cells; T-Lymphocytes, Helper-Inducer | 1994 |
Current management of asthma patients with corticosteroid resistance.
Topics: Anti-Inflammatory Agents; Asthma; Cyclosporine; Drug Resistance; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Steroids | 1996 |
T-cell/eosinophil interactions in the induction of asthma.
Topics: Asthma; CD4-Positive T-Lymphocytes; Cell Communication; Cell Movement; Chemokines; Cyclosporine; Eosinophils; Glucocorticoids; Growth Substances; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Interleukins; Lung; Monokines; T-Lymphocytes; Th2 Cells | 1996 |
Immunomodulation as asthma therapy: where do we stand?
Topics: Adjuvants, Immunologic; Administration, Inhalation; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Anti-Bacterial Agents; Antibodies, Monoclonal; Asthma; Bronchodilator Agents; Cell Adhesion; Cromolyn Sodium; Cyclosporine; Cytokines; Gold; Humans; Immunoglobulin G; Immunosuppressive Agents; Macrolides; Methotrexate; Nedocromil; Nitric Oxide Synthase; Phosphodiesterase Inhibitors; Theophylline | 1996 |
In vivo pharmacological effects of ciclosporin and some analogues.
Topics: Amino Acid Isomerases; Asthma; Carrier Proteins; Cyclosporine; Immunosuppression Therapy; Immunosuppressive Agents; Peptidylprolyl Isomerase; Psoriasis | 1996 |
Enhanced production and gene expression of IL-5 in bronchial asthma. Possible management of atopic diseases with IL-5 specific gene transcription inhibitor.
Topics: Animals; Asthma; CD4-Positive T-Lymphocytes; Cyclosporine; Gene Expression; Humans; Interleukin-5; Ionomycin; Tacrolimus; Tetradecanoylphorbol Acetate; Transcription, Genetic | 1996 |
Alternative treatments in the patient with intractable asthma.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Infective Agents; Antirheumatic Agents; Asthma; Cyclosporine; Dapsone; Humans; Hydroxychloroquine; Immunization, Passive; Immunosuppressive Agents; Methotrexate; Organogold Compounds; SRS-A; Troleandomycin | 1997 |
Experimental treatments for asthma.
Topics: Administration, Inhalation; Anti-Inflammatory Agents; Antirheumatic Agents; Asthma; Auranofin; Bradykinin; Cholinergic Antagonists; Chymases; Cyclosporine; Diuretics; Drugs, Investigational; Genetic Therapy; Heparin Antagonists; Humans; Immunosuppressive Agents; Kinins; Leukotriene Antagonists; Lidocaine; Muscarinic Antagonists; Neurokinin A; Phosphodiesterase Inhibitors; Prostaglandin-Endoperoxide Synthases; Receptors, Tachykinin; Serine Endopeptidases; T-Lymphocytes; Tryptases | 1997 |
T cells as orchestrators of the asthmatic response.
Topics: Animals; Asthma; Cyclosporine; Cytokines; Glucocorticoids; Humans; Models, Immunological; Receptors, Lymphocyte Homing; T-Lymphocytes | 1997 |
Immunopharmacology of human mast cells and basophils.
Topics: Adenylyl Cyclases; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Basophils; CD40 Ligand; Cyclosporine; Cytokines; Enzyme Activation; Enzyme Inhibitors; Glucocorticoids; Histamine Release; Humans; Inflammation; Mast Cells; Membrane Glycoproteins; Organ Specificity; Phosphodiesterase Inhibitors; Protein Kinase C; Protein-Tyrosine Kinases; Steroids; Tacrolimus | 1998 |
Role of T cells in asthma.
Topics: Animals; Asthma; Bronchi; Cyclosporine; Cytokines; Drug Resistance; Epitopes, T-Lymphocyte; Glucocorticoids; Humans; Immunosuppressive Agents; T-Lymphocytes | 1998 |
Newer therapeutic agents for asthma.
Topics: Adrenergic beta-Agonists; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Cyclosporine; Fluticasone; Forced Expiratory Volume; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Indoles; Leukotriene Antagonists; Lidocaine; Methotrexate; Phenylcarbamates; Salmeterol Xinafoate; Sulfonamides; Tosyl Compounds; Treatment Outcome | 1999 |
Difficult asthma: beyond the guidelines.
Topics: Asthma; Budesonide; Child; Chronic Disease; Cyclosporine; Drug Administration Routes; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Leukotriene Antagonists; Methotrexate; Patient Compliance; Patient Education as Topic; Terbutaline; Treatment Failure | 1999 |
Asthma--the changing face of drug therapy.
Topics: Adrenergic beta-Agonists; Anti-Asthmatic Agents; Asthma; Child; Cyclosporine; Enzyme Inhibitors; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Leukotriene Antagonists; Methotrexate; Phosphodiesterase Inhibitors | 2000 |
[Eosinophil apoptosis and airway inflammation in asthma].
Topics: Aminophylline; Animals; Apoptosis; Asthma; Bronchitis; Cyclosporine; Eosinophils; Humans | 1998 |
[Cytokines in the treatment of bronchial asthma].
Topics: Animals; Antibodies, Monoclonal; Asthma; Cyclosporine; Cytokines; Humans; Interferon-gamma; Interleukin 1 Receptor Antagonist Protein; Interleukin-4; Recombinant Proteins; Sialoglycoproteins | 1998 |
Cyclosporin as an oral corticosteroid sparing agent in stable asthma.
Topics: Administration, Oral; Asthma; Cyclosporine; Humans; Immunosuppressive Agents; Randomized Controlled Trials as Topic; Steroids | 2001 |
Is there a role for cyclosporine in asthma?
Topics: Asthma; Cyclosporine; Depression, Chemical; Dose-Response Relationship, Drug; Humans | 1992 |
14 trial(s) available for cyclosporine and Asthma, Bronchial
| Article | Year |
|---|---|
Topics: Adolescent; Adult; Animals; Asthma; Atrial Fibrillation; Autoantibodies; Biomarkers; Breast Neoplasms; Child; Conjunctivitis, Allergic; Cornea; COVID-19; Cyclosporine; Cytokines; Death, Sudden, Cardiac; Defibrillators, Implantable; Diet; Disease Models, Animal; Docetaxel; Double-Blind Method; Dry Eye Syndromes; Educational Status; Emulsions; Female; Fluorescein Angiography; Fluoresceins; Focus Groups; Heart Failure; Hemothorax; Humans; Inflammation; Keratoconus; Male; Meibomian Glands; Mice; Middle Aged; Multiple Sclerosis; Myocardial Infarction; Myocardium; Nerve Fibers; Nigeria; Obesity; Overweight; Pandemics; Primary Prevention; Prospective Studies; Qualitative Research; Registries; Retinal Ganglion Cells; Retinal Vessels; Schools; Sirolimus; Tertiary Care Centers; Th1 Cells; Th2 Cells; Tomography, Optical Coherence; Troponin I; Tumor Necrosis Factor-alpha; United States; Ventricular Remodeling | 2022 |
Cyclosporin A, apoptosis of BAL T-cells and expression of Bcl-2 in asthmatics.
Topics: Apoptosis; Asthma; Bronchial Provocation Tests; Bronchoalveolar Lavage Fluid; Cyclosporine; Double-Blind Method; Gene Expression; Genes, bcl-2; Humans; Immunosuppressive Agents; T-Lymphocytes; Time Factors | 2003 |
Treatment of steroid-dependent bronchial asthma with cyclosporin.
Topics: Adult; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Cyclosporine; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Male; Prednisone; Respiratory Function Tests; Time Factors | 1995 |
Cyclosporine A reduces T lymphocyte activity and improves airway hyperresponsiveness in corticosteroid-dependent chronic severe asthma.
Topics: Adrenal Cortex Hormones; Adult; Asthma; Chronic Disease; Cyclosporine; Female; Humans; Lymphocyte Activation; Male; Middle Aged; Peak Expiratory Flow Rate; Respiratory System; T-Lymphocytes | 1995 |
Clinical response to cyclosporin in chronic severe asthma is associated with reduction in serum soluble interleukin-2 receptor concentrations.
Topics: Asthma; Cross-Over Studies; Cyclosporine; Female; Humans; Immunoenzyme Techniques; Lymphocyte Activation; Male; Middle Aged; Peak Expiratory Flow Rate; Receptors, Interleukin-2; T-Lymphocytes | 1995 |
Interim monitoring of bivariate responses using repeated confidence intervals.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Analysis of Variance; Arthritis, Rheumatoid; Asthma; Clinical Trials as Topic; Confidence Intervals; Cyclosporine; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Models, Statistical; Quality of Life; Therapeutic Equivalency | 1994 |
Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma.
Topics: Administration, Oral; Adult; Aged; Asthma; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Peak Expiratory Flow Rate; Prednisolone; Respiratory Mechanics | 1996 |
Can clinical response to cyclosporin in chronic severe asthma be predicted by an in vitro T-lymphocyte proliferation assay?
Topics: Asthma; Cell Division; Cross-Over Studies; Cyclosporine; Dexamethasone; Female; Humans; Male; Middle Aged; Phytohemagglutinins; Predictive Value of Tests; T-Lymphocytes | 1996 |
Effect of cyclosporin A on the allergen-induced late asthmatic reaction.
Topics: Adult; Asthma; Bronchial Provocation Tests; Cross-Over Studies; Cyclosporine; Double-Blind Method; Eosinophils; Female; Forced Expiratory Volume; Humans; Hypersensitivity, Delayed; Hypersensitivity, Immediate; Immunosuppressive Agents; Leukocyte Count; Male; Middle Aged | 1997 |
The use of cyclosporin in corticosteroid dependent asthma.
Topics: Adolescent; Asthma; Child; Cyclosporine; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Male; Prednisolone; Respiratory Function Tests; Substance-Related Disorders | 1997 |
Attenuation of the allergen-induced late asthmatic reaction by cyclosporin A is associated with inhibition of bronchial eosinophils, interleukin-5, granulocyte macrophage colony-stimulating factor, and eotaxin.
Topics: Adolescent; Adult; Allergens; Asthma; Bronchi; Bronchoalveolar Lavage Fluid; Bronchoscopy; Chemokine CCL11; Chemokines, CC; Cyclosporine; Cytokines; Double-Blind Method; Eosinophils; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-5; Male; Middle Aged; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal | 2000 |
Pharmacokinetics, pharmacodynamics, and safety of inhaled cyclosporin A (ADI628) after single and repeated administration in healthy male and female subjects and asthmatic patients.
Topics: Administration, Inhalation; Adolescent; Adult; Asthma; Cyclosporine; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Sex Factors | 2000 |
[Effect of cyclosporine A on the clinical state and spirometric parameters in patients with steroid-dependent bronchial asthma].
Topics: Adult; Asthma; Cyclosporine; Double-Blind Method; Female; Humans; Male; Middle Aged; Spirometry; Substance-Related Disorders; Triamcinolone | 1992 |
Trial of cyclosporin in corticosteroid-dependent chronic severe asthma.
Topics: Adult; Asthma; Chronic Disease; Cyclosporine; Double-Blind Method; Female; Humans; Male; Maximal Expiratory Flow Rate; Middle Aged; Peak Expiratory Flow Rate; Prednisolone | 1992 |
64 other study(ies) available for cyclosporine and Asthma, Bronchial
| Article | Year |
|---|---|
3,5-Bis(trifluoromethyl)pyrazoles: a novel class of NFAT transcription factor regulator.
Topics: Animals; Asthma; Cell Division; Chemokine CCL11; Chemokines, CC; Combinatorial Chemistry Techniques; Cyclosporine; Cytokines; DNA-Binding Proteins; Genes, Reporter; Haplorhini; Humans; Immunosuppressive Agents; In Vitro Techniques; Interleukin-2; Interleukin-4; Interleukin-5; Interleukin-8; Jurkat Cells; Leukocytes, Mononuclear; Luciferases; NFATC Transcription Factors; Nuclear Proteins; Protein Synthesis Inhibitors; Pyrazoles; Rats; Transcription Factors | 2000 |
Cyclosporin A indirectly attenuates activation of group 2 innate lymphoid cells in papain-induced lung inflammation.
Topics: Allergens; Animals; Asthma; Cyclosporine; Cytokines; Disease Models, Animal; Immunity, Innate; Lung; Lymphocyte Activation; Lymphocytes; Mice; Mice, Inbred C57BL; Mice, Knockout; Papain; Pneumonia; Th2 Cells | 2018 |
Development of cyclosporine A-loaded dry-emulsion formulation using highly purified glycerol monooleate for safe inhalation therapy.
Topics: Animals; Anti-Inflammatory Agents; Antigens; Asthma; Cell Line; Cyclosporine; Disease Models, Animal; Emulsions; Glycerides; Male; Ovalbumin; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Sprague-Dawley; Respiratory Therapy; Surface-Active Agents | 2013 |
Interleukin-13-induced MUC5AC expression is regulated by a PI3K-NFAT3 pathway in mouse tracheal epithelial cells.
Topics: Animals; Asthma; Cells, Cultured; Chloride Channels; Chromones; Cyclosporine; Hepatocyte Nuclear Factor 3-beta; Humans; Interleukin-13; Mice; Morpholines; Mucin 5AC; Mucoproteins; Mucus; NFATC Transcription Factors; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Respiratory Mucosa; RNA, Messenger; Signal Transduction; Trachea; Up-Regulation | 2014 |
Treatment of feline asthma with ciclosporin in a cat with diabetes mellitus and congestive heart failure.
Topics: Animals; Asthma; Cardiomyopathy, Hypertrophic; Cat Diseases; Cats; Cyclosporine; Diabetes Mellitus; Dose-Response Relationship, Drug; Heart Failure; Immunosuppressive Agents; Treatment Outcome | 2015 |
Vernal Keratoconjunctivitis and immune-mediated diseases: One unique way to symptom control?
Topics: Adolescent; Asthma; Conjunctivitis, Allergic; Cyclosporine; Dermatitis, Atopic; Disease Progression; Humans; Immunoglobulin E; Male; Omalizumab; Th1 Cells; Th2 Cells | 2015 |
Development of an in vitro test system measuring transcriptional downregulatory activities on IL-13.
Topics: Animals; Asthma; Carcinogens; Cell Line, Tumor; Cyclosporine; Down-Regulation; Drug Evaluation, Preclinical; Genes, Reporter; Humans; Immunosuppressive Agents; Interleukin-13; Ionomycin; Ionophores; Mice; Rats; Tetradecanoylphorbol Acetate; Transcription, Genetic | 2009 |
In vitro and in vivo characterization on amorphous solid dispersion of cyclosporine A for inhalation therapy.
Topics: Administration, Inhalation; Animals; Asthma; Chemistry, Pharmaceutical; Cyclosporine; Excipients; Humans; Immunosuppressive Agents; Lung; Male; Particle Size; Powder Diffraction; Rats; Rats, Sprague-Dawley; X-Ray Diffraction | 2009 |
Reversal of methylprednisolone effects in allergen-exposed female BALB/c mice.
Topics: Administration, Intranasal; Allergens; Animals; Asthma; Bronchoalveolar Lavage Fluid; Cyclosporine; Disease Models, Animal; Drug Antagonism; Female; Glucocorticoids; Immunosuppressive Agents; Injections, Intraperitoneal; Lung; Methacholine Chloride; Methylprednisolone; Mice; Mice, Inbred BALB C; Ovalbumin; Respiratory Function Tests; Respiratory Hypersensitivity | 2010 |
Blocking cyclophilins in the chronic phase of asthma reduces the persistence of leukocytes and disease reactivation.
Topics: Animals; Anti-Asthmatic Agents; Asthma; Cyclophilins; Cyclosporine; Female; Leukocytes; Mice; Mice, Inbred BALB C; Secondary Prevention; Severity of Illness Index | 2011 |
Inhalable dry-emulsion formulation of cyclosporine A with improved anti-inflammatory effects in experimental asthma/COPD-model rats.
Topics: Administration, Inhalation; Animals; Anti-Inflammatory Agents; Asthma; Chemistry, Pharmaceutical; Cyclosporine; Drug Carriers; Emulsifying Agents; Emulsions; Glycerides; Lactose; Male; Particle Size; Povidone; Powders; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Sprague-Dawley; Solubility | 2012 |
Bronchial asthma developing after 15 years of immunosuppressive treatment following renal transplantation.
Topics: Adult; Asthma; Azathioprine; Cyclosporine; Female; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Kidney Transplantation; Prednisolone; Radiography; Time Factors | 2012 |
Ursolic acid, a potential PPARγ agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13, and IL-17 in a mouse model of allergic asthma.
Topics: Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Cell Count; Cell Line; Cyclosporine; Disease Models, Animal; Down-Regulation; Eosinophils; Female; GATA3 Transcription Factor; Hypersensitivity; Immunoglobulin E; Inflammation; Interleukin-13; Interleukin-17; Interleukin-5; Interleukins; Lung; Macrophages; Mice; Mice, Inbred BALB C; Ovalbumin; PPAR gamma; RNA, Messenger; STAT6 Transcription Factor; Th2 Cells; Triterpenes; Ursolic Acid | 2013 |
In vitro effects of ginkgolide B combined with cyclosporin A on T-lymphocyte activation and IL-5 expression in peripheral blood mononuclear cells from asthmatic subjects.
Topics: Adult; Asthma; Cells, Cultured; Cyclosporine; Cytokines; Diterpenes; Female; Flow Cytometry; Ginkgolides; Humans; In Vitro Techniques; Interleukin-5; Kuwait; Lactones; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Phytotherapy; Platelet Activating Factor; T-Lymphocytes; Tetradecanoylphorbol Acetate | 2002 |
Effects of cyclosporin A and a rapamycin derivative (SAR943) on chronic allergic inflammation in sensitized rats.
Topics: Acetylcholine; Animals; Asthma; Bronchial Provocation Tests; Cyclosporine; Disease Models, Animal; Eosinophils; Immunosuppressive Agents; Lymphocyte Count; Male; Muscle, Smooth; Rats; Rats, Inbred BN; Respiratory System; Sirolimus; T-Lymphocyte Subsets; Vasodilator Agents | 2003 |
A cyclosporin A/maltosyl-alpha-cyclodextrin complex for inhalation therapy of asthma.
Topics: Administration, Inhalation; Animals; Asthma; Cyclodextrins; Cyclosporine; Disease Models, Animal; Drug Therapy, Combination; Immunosuppressive Agents; Male; Maltose; Mice; Mice, Inbred BALB C; Powders; Solubility | 2003 |
Allergic disease after pediatric liver transplantation with systemic tacrolimus and cyclosporine a therapy.
Topics: Adolescent; Asthma; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Food Hypersensitivity; Humans; Immunosuppressive Agents; Liver Transplantation; Retrospective Studies; Tacrolimus | 2003 |
[Effect of inhaled cyclosporin A on antigen-induced airway inflammation in asthmatic rats].
Topics: Administration, Inhalation; Animals; Asthma; Bronchoalveolar Lavage Fluid; Cyclosporine; Eosinophils; Female; Immunosuppressive Agents; Leukocyte Count; Lung; Male; Ovalbumin; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2004 |
[Cross-talk between calcineurin and protein kinases in airway remodeling in asthma].
Topics: Animals; Asthma; Calcineurin; Calcineurin Inhibitors; Cyclic AMP-Dependent Protein Kinases; Cyclosporine; Guinea Pigs; Male; Mitogen-Activated Protein Kinase 1; Ovalbumin; Phosphorylation; Protein Kinase C; Random Allocation; Rats; Rats, Wistar; Respiratory Mucosa; Signal Transduction | 2005 |
Inhibitory effects of Actinidia polygama extract and cyclosporine A on OVA-induced eosinophilia and bronchial hyperresponsiveness in a murine model of asthma.
Topics: Actinidia; Animals; Anti-Asthmatic Agents; Antibodies; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cyclosporine; Enzyme-Linked Immunosorbent Assay; Eosinophilia; Flow Cytometry; Mice; Ovalbumin; Plant Extracts; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serine Proteinase Inhibitors | 2006 |
In vitro evaluation of the effect of cyclodextrin complexation on pulmonary deposition of a peptide, cyclosporin A.
Topics: Administration, Inhalation; Aerosols; Algorithms; alpha-Cyclodextrins; Asthma; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Cyclosporine; Graft Rejection; Immunosuppressive Agents; Lung; Lung Transplantation; Particle Size; Solubility; Spectrometry, Mass, Electrospray Ionization | 2006 |
Fritillaria cirrhosa, Anemarrhena asphodeloides, Lee-Mo-Tang and cyclosporine a inhibit ovalbumin-induced eosinophil accumulation and Th2-mediated bronchial hyperresponsiveness in a murine model of asthma.
Topics: Anemarrhena; Animals; Anti-Asthmatic Agents; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cell Proliferation; Cyclosporine; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Eosinophilia; Flow Cytometry; Fritillaria; Herbal Medicine; Histamine; Immunoglobulin E; Interferon-gamma; Interleukins; Lung; Male; Mice; Ovalbumin; Phytotherapy; Plant Preparations; Reverse Transcriptase Polymerase Chain Reaction | 2007 |
Effects of radix adenophorae and cyclosporine A on an OVA-induced murine model of asthma by suppressing to T cells activity, eosinophilia, and bronchial hyperresponsiveness.
Topics: Animals; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; CD4-Positive T-Lymphocytes; Cyclosporine; Cytokines; Female; Humans; Immunoglobulin E; Immunosuppressive Agents; Lung; Mice; Mice, Inbred C57BL; Ovalbumin; Plant Extracts; Pulmonary Eosinophilia | 2008 |
Regulation of interleukin-5 production by peripheral blood mononuclear cells from atopic patients with FK506, cyclosporin A and glucocorticoid.
Topics: Administration, Topical; Asthma; Calcium; Cyclosporine; Dexamethasone; Humans; Hypersensitivity, Immediate; Interleukin-5; Ionophores; Leukocytes, Mononuclear; Phorbol Esters; Tacrolimus | 1994 |
Cytokine production in patients with mite-sensitive bronchial asthma.
Topics: Allergens; Animals; Antibodies; Asthma; Cell Survival; Cyclosporine; Cytokines; Dexamethasone; Eosinophils; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interferon-gamma; Interleukin-3; Interleukin-5; Mites; Tacrolimus | 1994 |
Effects of various drugs (staurosporine, herbimycin A, ketotifen, theophylline, FK506 and cyclosporin A) on eosinophil viability.
Topics: Alkaloids; Asthma; Benzoquinones; Cell Survival; Cyclosporine; Eosinophils; Humans; Ketotifen; Lactams, Macrocyclic; Protein Kinase C; Protein-Tyrosine Kinases; Quinones; Rifabutin; Staurosporine; Tacrolimus; Theophylline | 1994 |
Eosinophil viability-enhancing activity in mite-sensitive bronchial asthma.
Topics: Adolescent; Adult; Analysis of Variance; Animals; Asthma; Case-Control Studies; Cell Degranulation; Cell Survival; Cyclosporine; Dexamethasone; Eosinophils; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interferon-gamma; Interleukin-3; Interleukin-5; Leukocytes, Mononuclear; Middle Aged; Mites; Tacrolimus | 1994 |
IL-5 production by CD4+ T cells of asthmatic patients is suppressed by glucocorticoids and the immunosuppressants FK506 and cyclosporin A.
Topics: Adult; Animals; Antigens, Dermatophagoides; Asthma; Base Sequence; Beclomethasone; Calcium; CD4-Positive T-Lymphocytes; Cells, Cultured; Cyclosporine; Dexamethasone; Dose-Response Relationship, Drug; Glucocorticoids; Glycoproteins; Humans; Hypersensitivity, Immediate; Interferon-gamma; Interleukin-2; Interleukin-4; Interleukin-5; Ionomycin; Lymphocyte Activation; Mites; Molecular Sequence Data; Protein Kinase C; Signal Transduction; Tacrolimus; Tetradecanoylphorbol Acetate | 1995 |
[Cyclosporin in severe steroid-requiring bronchial asthma].
Topics: Adult; Anti-Asthmatic Agents; Asthma; Cyclosporine; Drug Administration Schedule; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Respiratory Function Tests; Severity of Illness Index; Treatment Outcome | 1995 |
Effect of inhaled cyclosporin A on the allergen-induced late asthmatic response and increased in airway hyperresponsiveness in a guinea pig model of asthma.
Topics: Administration, Inhalation; Allergens; Animals; Asthma; Bronchial Hyperreactivity; Cyclosporine; Disease Models, Animal; Guinea Pigs; Hypersensitivity, Delayed; Male | 1994 |
[Cyclosporin A inhibits interleukin 5 (IL-5) production from human peripheral lymphocytes].
Topics: Asthma; Cyclosporine; Humans; Interleukin-2; Interleukin-5; Lymphocytes | 1994 |
The effect of dexamethasone, cyclosporine, and rapamycin on T-lymphocyte proliferation in vitro: comparison of cells from patients with glucocorticoid-sensitive and glucocorticoid-resistant chronic asthma.
Topics: Adult; Aged; Asthma; Cyclosporine; Dexamethasone; Drug Resistance; Female; Forced Expiratory Volume; Glucocorticoids; Humans; Immunosuppressive Agents; In Vitro Techniques; Interleukin-2; Lymphocyte Activation; Male; Middle Aged; Phytohemagglutinins; Polyenes; Reproducibility of Results; Sirolimus; T-Lymphocytes | 1994 |
[Cyclosporin in severe bronchial asthma].
Topics: Asthma; Chronic Disease; Cyclosporine; Humans | 1993 |
FK506 and cyclosporin A inhibit granulocyte/macrophage colony-stimulating factor production by mononuclear cells in asthma.
Topics: Asthma; Cells, Cultured; Cyclosporine; Enzyme-Linked Immunosorbent Assay; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Interleukin-5; Leukocytes, Mononuclear; Tacrolimus | 1995 |
Effect of cyclosporin-A on histamine release from tracheal strips of sensitized guinea pigs.
Topics: Animals; Asthma; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Freund's Adjuvant; Guinea Pigs; Histamine Release; Immunosuppressive Agents; Leukotriene C4; Leukotriene D4; Leukotriene E4; Male; Muscle Contraction; Muscle, Smooth; Ovalbumin; Radioimmunoassay; Trachea | 1996 |
Is the time for steroids in treatment of asthma over?
Topics: Anti-Inflammatory Agents; Asthma; Cyclosporine; Humans; Male; Middle Aged; Prednisolone | 1996 |
Glucocorticoid resistant asthma: T-lymphocyte steroid metabolism and sensitivity to glucocorticoids and immunosuppressive agents.
Topics: Administration, Topical; Adult; Aged; Androstadienes; Anti-Inflammatory Agents; Asthma; Beclomethasone; Budesonide; CD3 Complex; Cell Division; Cyclosporine; Dexamethasone; Drug Resistance; Female; Fluticasone; Glucocorticoids; Humans; Hydroxylation; Immunosuppressive Agents; Lymphocyte Activation; Male; Middle Aged; Molecular Structure; Mycophenolic Acid; Phytohemagglutinins; Pregnenediones; T-Lymphocytes; Tacrolimus | 1996 |
Inhibition of allergen-induced histamine release from human basophils by cyclosporine A and FK-506.
Topics: Adult; Allergens; Asthma; Basophils; Conjunctivitis, Allergic; Cyclosporine; Female; Histamine Release; Humans; Immunization, Passive; Immunoglobulin E; Immunosuppressive Agents; In Vitro Techniques; Male; Middle Aged; Pollen; Rhinitis, Allergic, Seasonal; Tacrolimus | 1997 |
Two cases of cutaneous phaeohyphomycosis by Alternaria alternata and Alternaria tenuissima.
Topics: Aged; Aged, 80 and over; Alternaria; Asthma; Cyclosporine; Dermatomycoses; Humans; Immunocompromised Host; Kidney Transplantation; Male; Methylprednisolone; Middle Aged | 1997 |
Cyclosporin A treatment and airways inflammation in corticosteroid-dependent asthma.
Topics: Adrenal Cortex Hormones; Asthma; Biopsy; Bronchi; Bronchoalveolar Lavage Fluid; Cell Count; Cyclosporine; Humans; Immunosuppressive Agents; Inflammation; Male; Middle Aged | 1998 |
Non-steroidal anti-inflammatory therapy for asthma.
Topics: Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Cyclosporine; Humans | 1998 |
Non-steroidal anti-inflammatory therapy for asthma.
Topics: Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Cyclosporine; Humans | 1998 |
Steroid-sparing drugs in steroid-dependent asthma: 1-cyclosporin-A.
Topics: Adult; Anti-Asthmatic Agents; Asthma; Cyclosporine; Female; Glucocorticoids; Humans; Male | 1997 |
Effect of inhaled cyclosporin on the rat airway: histologic and bronchoalveolar lavage assessment.
Topics: Administration, Inhalation; Animals; Asthma; Bronchi; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cyclosporine; Disease Models, Animal; Immunosuppressive Agents; Inflammation; Leukocyte Count; Macrophages; Ovalbumin; Rats; Rats, Sprague-Dawley; Reference Values | 1998 |
Effect of inhaled ingredients of a commercial cyclosporin A ampoule on airway inflammation.
Topics: Administration, Inhalation; Animals; Asthma; Bronchi; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cyclosporine; Disease Models, Animal; Eosinophils; Immunosuppressive Agents; Inflammation; Leukocyte Count; Ovalbumin; Rats | 1998 |
Differential effects of cyclosporine A after acute antigen challenge in sensitized cats in vivo and ex vivo.
Topics: Animals; Antigens, Helminth; Ascaris suum; Asthma; Cats; Cell Degranulation; Cyclosporine; Female; Male; Mast Cells; Muscle, Smooth; Serotonin; Trachea | 1998 |
Inflammatory basis of asthma.
Topics: Animals; Asthma; CD4-Positive T-Lymphocytes; Cell Degranulation; Cyclosporine; Disease Models, Animal; Eosinophils; Humans; Immunosuppressive Agents; Inflammation; Mast Cells | 1993 |
Control of IL-5 production by human helper T cells as a treatment for eosinophilic inflammation: comparison of in vitro and in vivo effects between selective and nonselective cytokine synthesis inhibitors.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Asthma; Clone Cells; Cyclosporine; Dexamethasone; Disease Models, Animal; Dose-Response Relationship, Drug; Eosinophilia; Humans; Immunosuppressive Agents; Inflammation; Interleukin-2; Interleukin-4; Interleukin-5; Macrolides; Mice; Mice, Inbred BALB C; T-Lymphocytes; T-Lymphocytes, Helper-Inducer; Tacrolimus | 2000 |
In vitro effects of Ginkgolide B on lymphocyte activation in atopic asthma: comparison with cyclosporin A.
Topics: Adult; Asthma; Biomarkers; Cyclosporine; Cytokines; Diterpenes; Female; Ginkgolides; Humans; In Vitro Techniques; Lactones; Lymphocyte Activation; Male | 2000 |
Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients.
Topics: Adrenal Cortex Hormones; Adult; Anti-Asthmatic Agents; Asthma; Case-Control Studies; Cyclosporine; Cystatin C; Cystatins; Cysteine Proteinase Inhibitors; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Middle Aged | 2000 |
Production of plasminogen activator inhibitor-1 by human mast cells and its possible role in asthma.
Topics: Asthma; Cells, Cultured; Cycloheximide; Cyclosporine; Dexamethasone; Fibrinolysis; Gene Expression Regulation; Humans; Kinetics; Lung; Mast Cells; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Receptors, IgE; RNA, Messenger; Tissue Plasminogen Activator | 2000 |
Serum concentration and circadian profiles of cathepsins B, H and L, and their inhibitors, stefins A and B, in asthma.
Topics: Adult; Aged; Asthma; Cathepsin B; Cathepsin H; Cathepsin L; Cathepsins; Circadian Rhythm; Cyclosporine; Cystatin A; Cystatin B; Cystatins; Cysteine Endopeptidases; Female; Humans; Male; Methylprednisolone; Middle Aged | 2001 |
Circadian and concentration profile of cathepsin S in sera from healthy subjects and asthmatic patients.
Topics: Adult; Aged; Anti-Inflammatory Agents; Asthma; Cathepsins; Circadian Rhythm; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged | 2001 |
The immunomodulatory drugs cyclosporin A, mycophenolate mofetil, and sirolimus (rapamycin) inhibit allergen-induced proliferation and IL-5 production by PBMCs from atopic asthmatic patients.
Topics: Asthma; Cyclosporine; Dexamethasone; Humans; Immunosuppressive Agents; Interleukin-5; Lymphocyte Activation; Mycophenolic Acid; Sirolimus | 2001 |
Effects of cyclosporin A by aerosol on airway hyperresponsiveness and inflammation in guinea pigs.
Topics: Acetylcholine; Aerosols; Animals; Anti-Asthmatic Agents; Asthma; Bronchoalveolar Lavage; Cyclosporine; Dexamethasone; Drug Synergism; Eosinophils; Female; Guinea Pigs; Histamine; Immunosuppressive Agents; Male; Ovalbumin | 2002 |
Regulation of IL-13 synthesis in human lymphocytes: implications for asthma therapy.
Topics: Animals; Anti-Asthmatic Agents; Asthma; Butadienes; Calcium Signaling; CD4-Positive T-Lymphocytes; Cells, Cultured; Cyclosporine; Disease Models, Animal; DNA-Binding Proteins; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Injections, Intraperitoneal; Interleukin-13; Leukocytes, Mononuclear; Lymphocytes; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; NF-kappa B; NFATC Transcription Factors; Nitriles; Nuclear Proteins; Pulmonary Eosinophilia; Rats; Rats, Inbred BN; RNA, Messenger; Tacrolimus; Time Factors; Transcription Factors | 2002 |
Anti-inflammatory effects of a cyclosporine receptor-binding compound, D-43787.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Asthma; Cell Division; Cyclophilin A; Cyclosporine; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Guinea Pigs; Humans; Immunosuppressive Agents; Indoles; Injections, Intraperitoneal; Injections, Subcutaneous; Leukocytes, Mononuclear; Lysine; Male; Peptidylprolyl Isomerase; Rats; Rats, Inbred BN; Rats, Inbred Lew; Th1 Cells; Th2 Cells | 2002 |
[Inhibitory effects of cyclosporin A and FK-506 on eosinophil chemotactic factor activity in culture supernatants of mononuclear cells from asthmatics].
Topics: Asthma; Chemotactic Factors, Eosinophil; Cyclosporine; Humans; Leukocytes, Mononuclear; Tacrolimus | 1992 |
Cyclosporin in chronic severe asthma.
Topics: Asthma; Cyclosporine; Humans | 1992 |
Cyclosporin and asthma.
Topics: Animals; Asthma; Cyclosporine; Humans | 1992 |
Cyclosporin and asthma.
Topics: Asthma; Cyclosporine; Humans | 1992 |
Cyclosporin A in asthma therapy: a pharmacological rationale.
Topics: Animals; Asthma; Cyclosporine; Eosinophilia; Eosinophils; Guinea Pigs; Humans; Immunity, Cellular; Lymphocytes; Rats | 1992 |
[Cyclosporine A inhibits allergen-induced late asthmatic response and increase of airway hyperresponsiveness in guinea pigs].
Topics: Airway Resistance; Animals; Asthma; Bronchi; Bronchoconstriction; Cyclosporine; Depression, Chemical; Guinea Pigs; Histamine Antagonists; Male; Ovalbumin; Passive Cutaneous Anaphylaxis; T-Lymphocytes, Helper-Inducer | 1991 |
Glucocorticoid resistance in chronic asthma. Peripheral blood T lymphocyte activation and comparison of the T lymphocyte inhibitory effects of glucocorticoids and cyclosporin A.
Topics: Adult; Asthma; Cell Division; Cells, Cultured; Chronic Disease; Cyclosporine; Depression, Chemical; Dose-Response Relationship, Drug; Drug Resistance; Flow Cytometry; Fluorescent Antibody Technique; Glucocorticoids; Humans; Interferon-gamma; Interleukin-2; Lymphocyte Activation; T-Lymphocytes | 1991 |